Found 0 matching trials
The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics PHASE1 The purpose of this study is to determine the effect of repeated dosing of ...
Show More Learn More & Join Trial
PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding PHASE2 This is an open, randomised, active-controlled, 2-period crossover study co...
Show More Location
Helsinki University Hospital, Department of Neurology
Learn More & Join Trial
Entacapone Combination With Imatinib for Treatment of GIST EARLY_PHASE1 This study evaluates the combination of entacapone and imatinib in the trea...
Show More Learn More & Join Trial
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps PHASE2 This study will evaluate the effect and safety of 611 in patients with Chro...
Show More Learn More & Join Trial
Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens PHASE2 The primary objective is to assess the effect of a single dose of two exper...
Show More Location
Kanta-Hämeen keskussairaala
Learn More & Join Trial
Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics PHASE1 The purpose of the study was to To investigate whether the administration o...
Show More Location
Human Pharmacology Unit (UFH) - BIAL - Portela & Cª, SA
Learn More & Join Trial
A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients PHASE2 This is a randomized, placebo-controlled, double-blind, 2-period study eval...
Show More Location
Hadassah Medical Center
Learn More & Join Trial
Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence PHASE2 The proposed study will look at cocaine dependent individuals and will cons...
Show More Learn More & Join Trial
Entacapone Augmentation for Schizophrenia NA This study is testing the hypothesis that Entacapone added to ongoing antip...
Show More Location
Rambam medical center
Learn More & Join Trial
Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis PHASE3 The primary objective of the study was to evaluate the efficacy of 611 in C...
Show More Location
Peking University People's Hospital
Learn More & Join Trial